IO BIOTECH INC (IOBT) Stock Analyst Earnings Estimates
NASDAQ:IOBT - Nasdaq - US4497781090 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 357.91% | N/A 116.98% | N/A 54.86% | N/A 34.75% | N/A 6.60% | N/A 21.41% | ||||||
| EBITDA YoY % growth | N/A | N/A | N/A | -71.32M -33.45% | -91.228M -27.91% | N/A -3.13% | N/A -11.42% | N/A -16.65% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.91M | -10.15M -2.42% | -41.23M -306.21% | -71.42M -73.22% | -91.443M -28.04% | N/A -5.16% | N/A -18.80% | N/A -13.77% | N/A 9.11% | N/A 49.85% | N/A 107.01% | N/A 2,326.34% | N/A 84.76% | N/A 35.17% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.50 46.25% | -2.16 13.60% | N/A 35.87% | N/A 1.77% | N/A 11.69% | N/A 46.52% | N/A 55.56% | N/A 146.43% | N/A 261.54% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.40 0.55% | -0.32 -7.10% | -0.33 -6.94% | -0.37 -2.00% | -0.31 23.08% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -28.063M 0.43% | -26.68M -32.10% | -25.695M -19.33% | -28.996M -9.40% | -33.311M -18.70% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.36 16.28% | -0.29 | -0.07 | -22.76% |
| Q2 2024 Q2Q % growth | -0.31 58.11% | -0.36 | 0.05 | 13.17% |
| Q1 2024 Q2Q % growth | -0.30 49.15% | -0.37 | 0.07 | 18.30% |
| Q4 2023 Q2Q % growth | -0.40 42.86% | -0.40 | 0.00 | -1.07% |
| Q3 2023 Q2Q % growth | -0.43 23.21% | -0.45 | 0.02 | 5.05% |
| Q2 2023 Q2Q % growth | -0.74 -15.62% | -0.67 | -0.07 | -9.92% |
| Q1 2023 Q2Q % growth | -0.59 1.67% | -0.72 | 0.13 | 17.95% |
| Q4 2022 Q2Q % growth | -0.70 32.72% | -0.60 | -0.10 | -16.32% |
| Q3 2022 Q2Q % growth | -0.56 98.48% | -0.68 | 0.12 | 18.06% |
| Q2 2022 Q2Q % growth | -0.64 | -0.69 | 0.05 | 7.27% |
| Q1 2022 Q2Q % growth | -0.60 | -0.67 | 0.07 | 10.42% |
| Q3 2021 Q2Q % growth | -36.88 | -1.63 | -35.25 | -2,159.80% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.3% | -1.3% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |